Your browser is no longer supported. Please, upgrade your browser.
Settings
OPK Opko Health, Inc. daily Stock Chart
OPK [NASD]
Opko Health, Inc.
Index- P/E- EPS (ttm)-0.14 Insider Own6.10% Shs Outstand564.09M Perf Week12.40%
Market Cap3.79B Forward P/E- EPS next Y-0.07 Insider Trans12.93% Shs Float336.50M Perf Month9.46%
Income-77.20M PEG- EPS next Q-0.05 Inst Own23.20% Short Float23.13% Perf Quarter-4.01%
Sales1.18B P/S3.20 EPS this Y26.00% Inst Trans-2.36% Short Ratio17.18 Perf Half Y-14.52%
Book/sh3.77 P/B1.78 EPS next Y63.20% ROA-2.80% Target Price13.25 Perf Year-38.21%
Cash/sh- P/C- EPS next 5Y12.00% ROE-3.70% 52W Range5.85 - 12.15 Perf YTD-27.85%
Dividend- P/FCF- EPS past 5Y-7.60% ROI-0.80% 52W High-44.77% Beta1.88
Dividend %- Quick Ratio1.50 Sales past 5Y112.80% Gross Margin47.40% 52W Low14.70% ATR0.21
Employees6041 Current Ratio1.70 Sales Q/Q-12.00% Oper. Margin-12.00% RSI (14)62.31 Volatility3.40% 3.19%
OptionableYes Debt/Eq0.06 EPS Q/Q-212.40% Profit Margin-6.50% Rel Volume1.64 Prev Close6.48
ShortableYes LT Debt/Eq0.05 EarningsAug 08 AMC Payout- Avg Volume4.53M Price6.71
Recom2.00 SMA207.62% SMA507.55% SMA200-12.00% Volume7,418,862 Change3.55%
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Sep-22-17 11:16AM  ETFs with exposure to OPKO Health, Inc. : September 22, 2017 Capital Cube
Sep-21-17 12:24PM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017 Capital Cube
08:00AM  Today's Research Reports on Trending Tickers: Amicus Therapeutics and Opko Health ACCESSWIRE
Sep-19-17 08:00AM  OPKOs BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care GlobeNewswire
Sep-15-17 03:03AM  OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : September 15, 2017 Capital Cube
Sep-14-17 04:30PM  Why Opko Health, Avis Budget Group, and Adomani Slumped Today Motley Fool -6.96%
07:32AM  Here's Why the Best Is Yet to Come for Opko Health Inc. Motley Fool
Sep-13-17 03:00PM  Biotech Stocks That Could Have Investors Looking At A Billion-Dollar Opportunity ACCESSWIRE
09:43AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : September 13, 2017 Capital Cube
Sep-12-17 08:36AM  Is the Options Market Predicting a Spike in Opko Health (OPK) Stock? Zacks
08:30AM  OPKOs GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings GlobeNewswire
Sep-11-17 02:00PM  Why Opko Health Stock Edged Higher in August Motley Fool
Sep-05-17 08:15AM  Cocrystal Pharma, HitGen and InterX Enter into Drug Discovery Collaboration Marketwired
Sep-01-17 10:04AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : September 1, 2017 Capital Cube
08:04AM  What the Biggest Investors Are Doing About Opko Health Stock's Dismal Performance Motley Fool
Aug-31-17 08:30AM  OPKO Health to Present at Upcoming September Conferences GlobeNewswire
Aug-28-17 07:45PM  We Got It Wrong With OPKO Health -- Now What? Motley Fool
Aug-24-17 06:15PM  Boy, Were We Wrong About Rite Aid and Opko Health Motley Fool
Aug-23-17 08:05AM  Xenetic Biosciences Announces Dismissal of Annual Meeting of Stockholders Business Wire
Aug-18-17 08:00AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics Inc. and Opko Health Inc. ACCESSWIRE
Aug-16-17 04:26PM  Opko Health's Biggest Believer: CEO Phillip Frost Puts His Money Where His Mouth Is Motley Fool
Aug-15-17 08:30AM  Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection Marketwired
08:05AM  Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update Business Wire
Aug-14-17 05:00PM  Xenetic Biosciences Announces Appointment of Three Directors to the Board Business Wire
Aug-11-17 07:01PM  Edited Transcript of OPK earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:04AM  Better Buy: Exact Sciences Corporation vs. Opko Health Motley Fool
06:30AM  OPKO Health (OPK) Posts Narrower-than-Estimated Loss in Q2 Zacks
Aug-10-17 03:50PM  Billionaire Phillip Frost defends his biotech firm on 'Mad Money' American City Business Journals
03:01AM  OPKO Health, Inc. is trading below its 50 day moving average : OPK-US : August 10, 2017 Capital Cube
Aug-09-17 07:42PM  Cramer Remix: How low expectations drove this stock to ne... CNBC Videos
07:12PM  Major biotech CEO says new prostate test will revolutioni... CNBC Videos
Aug-08-17 09:32PM  OPKO Health reports 2Q loss Associated Press
05:00PM  ETFs with exposure to OPKO Health, Inc. : August 8, 2017 Capital Cube
04:30PM  Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update Marketwired
04:15PM  OPKO Health Reports Second Quarter 2017 Business and Financial Results GlobeNewswire
Aug-03-17 11:05PM  OPKO Health, Inc. Value Analysis (NASDAQ:OPK) : August 4, 2017 Capital Cube
08:00AM  OPKO Health to Announce 2017 Second Quarter Financial Results on August 8, 2017 GlobeNewswire
Aug-02-17 09:16AM  OPKO Health, Inc. breached its 50 day moving average in a Bearish Manner : OPK-US : August 2, 2017 Capital Cube
08:00AM  Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million PR Newswire
Jul-28-17 04:37PM  ETFs with exposure to OPKO Health, Inc. : July 28, 2017 Capital Cube
Jul-20-17 08:45AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : July 20, 2017 Capital Cube
Jul-18-17 04:05PM  Xenetic Biosciences Announces Adjournment of Annual Meeting of Stockholders until Wednesday, August 16, 2017 Business Wire
02:00PM  ETFs with exposure to OPKO Health, Inc. : July 18, 2017 Capital Cube
Jul-07-17 03:22PM  ETFs with exposure to OPKO Health, Inc. : July 7, 2017 Capital Cube
Jul-03-17 08:00AM  Today's Research Reports on Stocks to Watch: CEL-SCI Corporation and Opko Health Accesswire
Jun-29-17 06:42PM  Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
Jun-26-17 04:37PM  ETFs with exposure to OPKO Health, Inc. : June 26, 2017 Capital Cube
04:26PM  How Things Look for Opko Health, Inc. in 3 Charts Motley Fool
08:35AM  Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer Business Wire
Jun-22-17 08:30AM  OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD GlobeNewswire -5.51%
08:14AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : June 22, 2017 Capital Cube
Jun-16-17 04:09PM  ETFs with exposure to OPKO Health, Inc. : June 16, 2017 Capital Cube
Jun-15-17 09:12AM  OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults GlobeNewswire
Jun-14-17 09:27AM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-13-17 08:00AM  Today's Research Reports on Stocks to Watch: Exelixis and Opko Health Accesswire
Jun-07-17 08:00AM  OPKOS GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing GlobeNewswire
Jun-05-17 11:17AM  OPKO Health Provides Commercial Update for RAYALDEE GlobeNewswire -6.26%
10:55AM  Here's Why Opko Health Inc. Slipped 18.8% in May Motley Fool
Jun-01-17 04:15PM  James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma, Inc. Marketwired
May-25-17 08:43AM  Is the Options Market Predicting a Spike in Opko Health (OPK) Stock? Zacks
08:32AM  3 Value Stocks You Might Not Have Thought Of Motley Fool
May-22-17 07:00AM  Xenetic Biosciences Receives Program Update from Partner Shires Phase 1/2 Study Evaluating SHP656 in Development as a Long-acting Treatment for Hemophilia A Business Wire
07:00AM  MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering PR Newswire
May-18-17 08:00AM  OPKO Healths 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting GlobeNewswire
May-16-17 07:00AM  Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update Business Wire
May-15-17 08:00AM  OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting GlobeNewswire -5.42%
May-10-17 12:56AM  Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents -7.04%
May-09-17 05:16PM  OPKO Health reports 1Q loss Associated Press
04:32PM  CORRECTION -- OPKO Health Inc. GlobeNewswire
04:10PM  OPKO Health Reports 2016 Financial and Operating Results GlobeNewswire
03:05PM  Investor Network: OPKO Health, Inc. to Host Earnings Call Accesswire
08:35AM  Xenetic Biosciences to Host 2017 First Quarter Update Conference Call Business Wire
May-08-17 05:03PM  ETFs with exposure to OPKO Health, Inc. : May 8, 2017 Capital Cube
08:00AM  OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017 GlobeNewswire
May-01-17 08:30AM  Xenetic Biosciences Presents Case Study of PolyXen Platform Technology at the 13th Annual Protein Engineering Summit (PEGS) Boston Business Wire
Apr-27-17 04:12PM  ETFs with exposure to OPKO Health, Inc. : April 27, 2017 Capital Cube
Apr-24-17 04:15PM  Cocrystal Pharma Receives Investment Through Private Placement Marketwired
Apr-20-17 07:35AM  Xenetic Biosciences PolyXen Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston Business Wire
Apr-19-17 09:21AM  3 Beaten-Up Healthcare Stocks: Are They Bargains? Motley Fool +5.77%
Apr-17-17 01:02PM  ETFs with exposure to OPKO Health, Inc. : April 17, 2017 Capital Cube
Apr-05-17 05:14PM  ETFs with exposure to OPKO Health, Inc. : April 5, 2017 Capital Cube
Apr-04-17 07:05AM  Xenetic Biosciences Expands Executive Management Team with Appointment of James F. Parslow, MBA, CPA as Chief Financial Officer Business Wire
Mar-30-17 06:20PM  OPKO Health, Inc. :OPK-US: Earnings Analysis: 2016 By the Numbers : March 30, 2017 Capital Cube
Mar-29-17 08:11AM  OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : March 29, 2017 Capital Cube
Mar-28-17 06:30AM  ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors GlobeNewswire
Mar-25-17 12:03PM  3 Stocks That Could Double Your Money Motley Fool
Mar-23-17 04:33PM  OPKO HEALTH, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
Mar-22-17 10:48AM  Opko Gets Orphan Status for Genetic Disorder Drug Investopedia
08:00AM  OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder GlobeNewswire
Mar-16-17 04:33PM  Benzinga's Option Alert Recap From March 16
Mar-14-17 08:30AM  OPKO Health's GeneDx to have Significant Presence at ACMG 2017 GlobeNewswire
08:00AM  OPKO Health to Participate in the Barclays Global Healthcare Conference GlobeNewswire
Mar-11-17 12:04PM  Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc. at Motley Fool
Mar-09-17 09:30AM  Biotech's Rally in 2017 Stumbles on Pricing Concerns: Today's Research Reports on Opko Health and Cerus Accesswire
Mar-08-17 01:04PM  OPKO HEALTH, INC. Financials
10:56AM  OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest
08:00AM  OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder GlobeNewswire
Mar-07-17 06:18PM  Opko Health subsidiary launches prenatal testing tool at bizjournals.com
11:21AM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
08:00AM  OPKO Subsidiary GenPath Womens Health Announces the Availability of ClariTest GlobeNewswire
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3-4 chronic kidney disease patients with vitamin D deficiency; and VARUBI for chemotherapy-induced nausea and vomiting. This segment is also developing TT401, which is in Phase II clinical trials for type 2 diabetes and obesity; TT701, an androgen receptor modulator that is in Phase II clinical trials for androgen deficiency indications; and hGH-CTP, a growth hormone injection that is in Phase III clinical trials. In addition, it engages in developing and commercializing hGH-CTP, a recombinant human growth hormone product that is in Phase III; developing Factor VIIa drug for hemophilia that is in Phase IIa, an NK-1 compound, and drugs for treating asthma and chronic obstructive pulmonary disease; developing and producing specialty active pharmaceutical ingredients; and discovery of drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, this segment engages in the development, manufacture, and sale of pharmaceutical, nutraceutical, and veterinary products; and markets and distributes pharmaceutical and natural products. Additionally, OPKO Health, Inc. operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanSep 19Buy6.0115,00090,099395,000Sep 20 06:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 18Buy6.0040,000240,000380,000Sep 19 06:26 AM
Logal AdamSr. Vice President, CFOSep 15Buy6.031,5009,045162,793Sep 18 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 15Buy6.0180,000480,411340,000Sep 18 06:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 14Buy5.98260,0001,555,624260,000Sep 15 08:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 25Buy6.1725,000154,236164,234,443Aug 28 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 24Buy6.2410,00062,353164,209,443Aug 25 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 23Buy6.1312,00073,554164,199,443Aug 24 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 22Buy6.131,80011,034164,187,443Aug 23 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 21Buy6.1025,000152,539164,185,643Aug 22 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 17Buy5.9650,000298,048164,160,643Aug 18 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 16Buy6.0440,000241,734164,110,643Aug 17 07:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 15Buy6.0825,000152,074164,070,643Aug 16 07:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 14Buy6.1510,00061,527164,045,643Aug 15 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 11Buy6.1910,00061,895164,035,643Aug 14 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 10Buy6.2339,000242,794164,025,643Aug 11 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 09Buy6.3518,000114,227163,986,643Aug 10 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 08Buy6.055,00030,250163,968,643Aug 09 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 02Buy6.1525,000153,740163,963,643Aug 03 07:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 01Buy6.2546,600291,046163,938,643Aug 02 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 28Buy6.3035,100221,012163,892,043Jul 31 06:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 27Buy6.3423,600149,687163,856,943Jul 28 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 26Buy6.3936,200231,214163,833,343Jul 27 06:21 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 25Buy6.4139,800255,170163,797,143Jul 26 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 24Buy6.4245,000289,050163,757,343Jul 25 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 20Buy6.465,40034,872163,712,343Jul 21 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 17Buy6.041,80010,871163,706,943Jul 18 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 14Buy6.1612,60077,564163,705,143Jul 17 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 12Buy6.123,60022,050163,692,543Jul 13 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 10Buy6.1950,000309,570163,688,943Jul 11 06:38 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 06Buy6.2925,000157,141163,638,943Jul 07 06:26 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 03Buy6.4460,800391,396163,613,943Jul 05 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 30Buy6.583,60023,700163,553,143Jul 03 08:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 28Buy6.871,80012,366163,549,543Jun 29 06:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 27Buy6.7721,800147,541163,547,743Jun 28 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 26Buy6.971,80012,543163,525,943Jun 27 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 22Buy6.72131,000880,268163,524,143Jun 23 06:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 15Buy6.43200,0001,285,692163,393,143Jun 16 06:17 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 13Buy6.517,20046,901163,193,143Jun 14 06:33 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 12Buy6.371,80011,458163,185,943Jun 13 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 09Buy6.3925,000159,643163,184,143Jun 12 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy6.2755,600348,785163,159,143Jun 08 07:39 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy6.3030,000189,147163,103,543Jun 07 07:26 AM
LERNER RICHARD ADirectorJun 05Buy6.3110,00063,135166,172Jun 06 07:16 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 05Buy6.3155,000347,135163,073,543Jun 06 07:17 AM
PFENNIGER RICHARD C JRDirectorJun 02Option Exercise3.4320,00068,600170,000Jun 05 09:49 AM
PAGANELLI JOHN ADirectorJun 01Buy6.175,00030,8409,175Jun 02 11:36 AM
Rubin Steven DExecutive VP-AdministrationMay 31Buy6.102,00012,2005,685,915Jun 01 09:27 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy6.11207,7001,269,461163,018,543Jun 01 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 30Buy6.2818,600116,773162,810,843May 31 06:48 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 26Buy6.3164,600407,432162,792,243May 30 07:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 25Buy6.3826,000165,786162,727,643May 26 07:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 24Buy6.4242,200270,959162,701,643May 25 06:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy6.43120,000772,174162,659,443May 23 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 19Buy6.609,20060,685162,539,443May 22 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 18Buy6.5920,000131,808162,530,243May 19 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 17Buy6.5470,800463,256162,510,243May 18 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 16Buy6.6127,800183,634162,439,443May 17 06:45 AM
HSIAO JANE PH DVice Chairman & CTOMay 11Buy6.9320,000138,50024,773,133May 12 10:53 AM
Rubin Steven DExecutive VP-AdministrationMay 11Buy6.912,00013,8145,683,915May 11 02:17 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 10Buy6.961,125,0007,829,775162,411,643May 11 06:41 AM
HSIAO JANE PH DVice Chairman & CTOMay 10Buy6.9740,000278,70524,753,133May 11 06:50 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 08Buy7.22100,000722,248161,286,643May 09 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 05Buy7.5210,00075,234161,186,643May 08 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 04Buy7.5111,80088,592161,176,643May 05 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 03Buy7.5311,00082,784161,164,843May 04 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 02Buy7.5815,000113,760161,153,843May 02 06:56 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 01Buy7.684,70036,104161,138,843May 02 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 28Buy7.789,00070,010161,134,143May 01 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 27Buy7.8122,500175,787161,125,143Apr 28 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 26Buy7.845,00039,196161,102,643Apr 27 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 21Buy7.4819,000142,197161,097,643Apr 24 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 19Buy7.4915,000112,291161,078,643Apr 20 07:27 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 18Buy7.2627,800201,790161,063,643Apr 19 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy7.4813,600101,676161,035,843Apr 18 07:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 13Buy7.5830,800233,400161,022,243Apr 14 07:45 AM
Rubin Steven DExecutive VP-AdministrationApr 12Option Exercise2.36265,000625,4005,840,251Apr 13 04:25 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy7.4918,000134,909160,991,443Apr 12 06:12 AM
Yu Alice Lin-TsingDirectorApr 10Option Exercise4.7220,00094,400100,000Apr 11 04:14 PM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy7.6033,000250,842160,973,443Apr 11 07:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 07Buy7.5828,000212,220160,940,443Apr 10 08:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 06Buy7.5828,600216,881160,912,443Apr 07 08:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 05Buy7.6944,500342,042160,883,843Apr 06 07:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 04Buy7.697,40056,943160,839,343Apr 05 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 03Buy7.8221,600168,908160,831,943Apr 04 07:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 31Buy8.001,80014,400160,810,343Apr 03 07:34 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 30Buy8.0210,60085,043160,808,543Mar 31 07:40 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 29Buy8.149,20074,847160,797,943Mar 30 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 28Buy8.033,60028,895160,788,743Mar 29 08:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 24Buy7.753,60027,917160,785,143Mar 27 06:26 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 23Buy7.7112,20094,024160,781,543Mar 24 07:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 21Buy7.855,80045,531160,769,343Mar 22 07:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 20Buy7.9911,00087,924160,763,543Mar 21 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 17Buy8.199,00073,710160,752,543Mar 20 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 15Buy8.031,80014,454160,743,543Mar 16 07:10 AM
Logal AdamSr. Vice President, CFOMar 14Sale8.07112,975911,674161,293Mar 15 06:31 PM
Logal AdamSr. Vice President, CFOMar 13Option Exercise1.07264,207282,956309,996Mar 15 06:31 PM
LERNER RICHARD ADirectorMar 13Option Exercise2.0520,00041,00050,000Mar 15 06:30 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 10Buy7.971,80014,345160,741,743Mar 13 07:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 09Buy7.843,60028,209160,739,943Mar 10 07:22 AM